Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

por Eliakim-Raz, Noa, Stemmer, Amos, Ghantous, Nassem, Ness, Asaf, Awwad, Muhammad, Leibovici-Weisman, Yaara, Stemmer, Salomon M.
Publicado 2022

Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study

por Pertzov, Barak, Shmueli, Einat, Ben Zvi, Haim, Massarweh, Amir, Barkan, Tamar, Ness, Asaf, Shostak, Yael, Freidkin, Lev, Shtraichman, Osnat, Kramer, Mordechai R.
Publicado 2022

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years

por Bar-Haim, Erez, Eliakim-Raz, Noa, Stemmer, Amos, Cohen, Hila, Elia, Uri, Ness, Asaf, Awwad, Muhammad, Ghantous, Nassem, Moskovits, Neta, Rotem, Shahar, Stemmer, Salomon M.
Publicado 2022

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

por Eliakim-Raz, Noa, Stemmer, Amos, Leibovici-Weisman, Yaara, Ness, Asaf, Awwad, Muhammad, Ghantous, Nassem, Erez, Noam, Bareket-Samish, Avital, Levy-Barda, Adva, Ben-Zvi, Haim, Moskovits, Neta, Bar-Haim, Erez, Stemmer, Salomon M
Publicado 2022